Zingiber officinale (ginger) compounds have tetracycline-resistance modifying effects against clinical extensively drug-resistant Acinetobacter baumannii

Phytotherapy Research

Volumn 24, Issue 12, 2010, Pages 1825-1830

  Wang, Hui Min ^a   Chen, Chung Yi ^b   Chen, Hsi An ^a   Huang, Wan Chun ^c   Lin, Wei Ru ^c   Chen, Tun Chieh ^c   Lin, Chun Yu ^c   Chien, Hsin Ju ^c   Lu, Po Liang ^c   Lin, Chiu Mei ^d   Chen, Yen Hsu ^c  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b FOOYIN UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL ILAN UNIVERSITY   (Taiwan)

Author keywords

Acinetobacter baumannii; antimicrobial activities; antioxidant; extensively drug resistant; Zingiber officinale

Indexed keywords

AMPICILLIN; ASCORBIC ACID; CEFAZOLIN; CEFEPIME; CEFMETAZOLE; CEFTAZIDIME; CEFTRIAXONE; COTRIMOXAZOLE; DEHYDROGINGERDIONE; GENTAMICIN; GINGER EXTRACT; GINGEROL; MANGANESE DIOXIDE; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SCAVENGER; SHOGAOL; SULTAMICILLIN; TETRACYCLINE; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIOXIDANT ACTIVITY; ARTICLE; CHEMICAL COMPOSITION; HOSPITAL INFECTION; MINIMUM INHIBITORY CONCENTRATION;

ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; ANTIOXIDANTS; CATECHOLS; DRUG EVALUATION, PRECLINICAL; FATTY ALCOHOLS; GINGER; GUAIACOL; MICROBIAL SENSITIVITY TESTS; PLANT EXTRACTS; RHIZOME; TETRACYCLINE RESISTANCE;

ACINETOBACTER BAUMANNII; BACTERIA (MICROORGANISMS); ZINGIBER OFFICINALE;

EID: 78649651787     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3201     Document Type: Article

References (32)

1. Afzal M, Al-Hadidi D, Menon M, Pesek J, Dhami M., 2001. Ginger: an ethnomedical, chemical and pharmacological review. Drug Metab Drug Interact 18: 159-190.
2. Akoachere JF, Chenwi EB, Njock TE, Anong DN., 2002. Anti-bacterial effect of Zingiber officinale and Garcinia kola on respiratory tract pathogens. East Afr Med J 79: 588-592.
3. Arias CA, Murray BE., 2009. Antibiotic-resistant bugs in the 21st century-A clinical super-challenge. N Engl J Med 360: 439-443.
4. Betoni JE, Mantovani RP, Barbosa LN, Di Stasi LC, Fernandes Jr A., 2006. Synergism between plant extract and antimicrobial drugs used on Staphylococcus aureus diseases. Mem Inst Oswaldo Cruz 101: 387-390.
5. Chang CP, Chang JY, Wang FY, Chang JG., 1995. The effect of Chinese medicinal herb Zingiberis rhizome extract on cytokine secretion by human peripheral blood mononuclear cells. J Ethnopharmacol 48: 13-19.
6. Chen BH, Wu PY, Chen KM, Fu TF, Wang HM, Chen CY., 2009. Anti-allergic potential on RBL-2H3 cells of some phenolic constituents of Zingiber officinale (Ginger). J Nat Prod 72: 950-953.
7. CLSI. 2009. M100-S19. Performance Standards for Antimicrobial Susceptibility Testing-Nineteenth Information Supplement. Clinical and Laboratory Standards Institute: Wayne, PA.
8. Doi Y, Husain S, Potoski BA, McCurry KR, Paterson DL., 2009. Extensively drug-resistant Acinetobacter baumannii. Emerg Infect Dis 15: 980-982.
9. Falagas M, Karageorgopoulos DE., 2008. Pan-drug Resistance (PDR), Extensive drug resistance (XDR), and multi-drug resistance (MDR) among gram-negative bacilli: Need for international harmonization in terminology. Clin Infect Dis 46: 1121-1122.
10. Fernandes Jr A, Balestrin EC, Betoni JE, Orsi Rde O, Da Cunha Mde L, Montelli AC., 2005. Propolis: anti-Staphylococcus aureus activity and synergism with antimicrobial drugs. Mem Inst Oswaldo Cruz 100: 563-566.
11. Ficker C, Smith ML, Akpagana K, et al,. 2003. Bio-assay-guided isolation and identification of antifungal compounds from ginger. Phytother Res 17: 897-902.
12. Goto C, Kasuya S, Koga K, Ohtomo H, Kagei N., 1990. Lethal efficacy of extract from Zingiber officinale (traditional Chinese medicine) or [6]-shogaol and [6]-gingerol in Anisakis larvae in vitro. Parasitol Res 76: 653-656.
13. Hiserodt RD, Franzblau SG, Rosen RT., 1998. Isolation of 6-, 8-, and 10-gingerol from ginger rhizome by HPLC and preliminary evaluation of inhibition of Mycobacterium avium and Mycobacterium tuberculosis. J Agric Food Chem 46: 2504-2508.
14. Hsueh PR, Liu CY, Luh KT., 2002. Current status of anti-microbial resistance in Taiwan. Emerg Infect Dis 8: 132-137.
15. Jeong CH, Bode AM, Pugliese A, et al,. 2009. [6]-Gingerol suppresses colon cancer growth by targeting leukotriene A4 hydrolase. Cancer Res 69: 5584-5591.
16. Mahady GB, Pendland SL, Yun GS, Lu ZZ, Stoia A., 2003. Ginger (Zingiber officinale Roscoe) and the gingerols inhibit the growth of Cag A+ strains of Helicobacter pylori. Anticancer Res 23: 3699-3702.
17. Matsuda A, Wang Z, Takahashi S, Tokuda T, Miura N, Hasegawa J., 2009. Up-regulation of mRNA of retinoid binding protein and fatty acid binding protein by cholesterol enriched-diet and effect of ginger on lipid metabolism. Life Sci 84: 903-907.
18. Munoz-Price LS, Weinstein RA., 2008. Acinetobacter infection. N Engl J Med 358: 1271-1281.
19. Nagoshi C, Shiota S, Kuroda T, et al,. 2006. Synergistic effect of [10]-gingerol and aminoglycosides against Vancomycin-resistant enterococci (VRE). Biol Pharm Bull 29: 443-447.
20. Nariman F, Eftekhar F, Habibi Z, Falsafi T., 2004. Anti-Helicobacter pylori activities of six Iranian plants. Helicobacter 9: 146-151.
21. Park M, Bae J, Lee DS., 2008. Anti-bacterial activity of [10]-gingerol and [12]-gingerol isolated from ginger rhizome against periodontal bacteria. Phytother Res 22: 1446-1449.
22. Peleg AY, Seifert H, Paterson DL., 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21: 538-582.
23. Policegoudra RS, Divakar S, Aradhya SM., 2007. Identification of difurocumenonol, a new antimicrobial compound from mango ginger (Curcuma amada Roxb.) rhizome. J Appl Microbiol 102: 1594-1602.
24. Roberts MC., 2003. Tetracycline therapy: update. Clin Infect Dis 36: 462-467.
25. Sekiwa Y, Kubota K, Kobayashi A., 2000. Isolation of novel glucosides related to gingerdiol from ginger and their antioxidative activities. J Agric Food Chem 48: 373-377.
26. Shoji N, Iwasa A, Takemoto T, Ishida Y, Ohizumi Y., 1982. Cardiotonic principles of ginger (Zingiber officinale Roscoe). J Pharm Sci 71: 1174-1175.
27. Smith EC, Williamson EM, Wareham N, Kaatz GW, Gibbons S., 2007. Antibacterials and modulators of bacterial resistance from the immature cones of Chamaecyparis lawsoniana. Phytochemistry 68: 210-217.
28. Tegos G, Frank RS, Olga L, Kim L., 2002. Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials. Antimicrob Agents Chemother 46: 3133-3141.
29. Ultee A, Bennik MHJ, Moezelaar R., 2002. The phenolic hydroxyl group of carvacrol is essential for action against the food-borne pathogen Bacillus cereus. Appl Environ Microbiol 68: 1561-1568.
30. Uz E, Karatas OF, Mete E, et al,. 2009. The effect of dietary ginger (Zingiber officinals Roscoe) on renal ischemia/reperfusion injury in rat kidneys. Renal Failure 31: 251-260.
31. Wang KJ, Zhang YJ, Yang CR., 2005. Anti-oxidant phenolic constituents from Fagopyrum dibotrys. J Ethnopharmacol 99: 259-264.
32. White B., 2007. Ginger: an overview. Am Fam Physician 75: 1689-1691.